4D Molecular Therapeutics
Design and develop transformative gene therapy products using our proprietary. Learn more
Launch date
Employees
Market cap
€752m
Enterprise valuation
€271m (Public information from Sep 2024)
Share price
$13.5 FDMT
Emeryville California (HQ)
Authorizing premium user...